These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 3137102

  • 1. Pulsatile luteinizing hormone-releasing hormone treatment of male hypogonadotropic hypogonadism.
    Aulitzky W, Frick J, Galvan G.
    Fertil Steril; 1988 Sep; 50(3):480-6. PubMed ID: 3137102
    [Abstract] [Full Text] [Related]

  • 2. Predictive factors for pituitary response to pulsatile GnRH therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF, Wang X, Zheng JJ, Liu ZX, Xu HL, Huang BK, Nie M, Wu XY.
    Asian J Androl; 2018 Sep; 20(4):319-323. PubMed ID: 29516878
    [Abstract] [Full Text] [Related]

  • 3. Induction of male puberty by long-term pulsatile subcutaneous LH-RH therapy.
    Skarin G, Nillius SJ, Ahlsten G, Tuvemo T, Wide L.
    Ups J Med Sci; 1984 Sep; 89(1):73-80. PubMed ID: 6429918
    [Abstract] [Full Text] [Related]

  • 4. Treatment of idiopathic hypogonadotropic hypogonadism in men with luteinizing hormone-releasing hormone: a comparison of treatment with daily injections and with the pulsatile infusion pump.
    Shargil AA.
    Fertil Steril; 1987 Mar; 47(3):492-501. PubMed ID: 3549367
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF, Liu ZX, Nie M, Wang X, Xu HL, Huang BK, Zheng JJ, Min L, Kaiser UB, Wu XY.
    Asian J Androl; 2017 Mar; 19(6):680-685. PubMed ID: 28051040
    [Abstract] [Full Text] [Related]

  • 15. Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids.
    Valenti S, Giusti M, McGuinness D, Guido R, Mori PG, Giordano G, Dahl KD.
    Eur J Endocrinol; 1995 Jul; 133(1):48-56. PubMed ID: 7627337
    [Abstract] [Full Text] [Related]

  • 16. Induction of puberty in a patient with hypogonadotropic hypogonadism by pulsatile, subcutaneous infusions of LH-RH.
    Vierhapper H.
    Exp Clin Endocrinol; 1984 Jul; 84(1):126-8. PubMed ID: 6383847
    [Abstract] [Full Text] [Related]

  • 17. Pulsatile gonadotropin-releasing hormone therapy in male patients with Kallmann's syndrome or constitutional delay of puberty.
    Happ J, Ditscheid W, Krause U.
    Fertil Steril; 1985 Apr; 43(4):599-608. PubMed ID: 3921412
    [Abstract] [Full Text] [Related]

  • 18. Events surrounding the initiation of puberty with long term subcutaneous pulsatile gonadotropin-releasing hormone in a female patient with Kallman's syndrome.
    Seibel MM, Claman P, Oskowitz SP, McArdle C, Weinstein FG.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):575-9. PubMed ID: 3926811
    [Abstract] [Full Text] [Related]

  • 19. Induction of puberty in men by long-term pulsatile administration of low-dose gonadotropin-releasing hormone.
    Hoffman AR, Crowley WF.
    N Engl J Med; 1982 Nov 11; 307(20):1237-41. PubMed ID: 6813732
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.